Apotex Inc. v. Sanofi-Aventis

JurisdictionFederal Jurisdiction (Canada)
CourtCourt of Appeal (Canada)
JudgeNoël, Pelletier and Gauthier, JJ.A.
Citation2013 FCA 209,[2013] N.R. Uned. 144,[2013] N.R. Uned. 144 (FCA)
Date16 September 2013
Subject MatterPRACTICE,COURTS

Get this document and AI-powered insights with a free trial of vLex and Vincent AI

Get Started for Free

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex
3 practice notes
  • The Best Of The Decade – Canadian Patent Law In The 2010s
    • Canada
    • Mondaq Canada
    • 18 Febrero 2020
    ...ingredient such as a salt, ester, enantiomer, solvate or polymorph. Sanofi-Aventis v Apotex Inc, 2013 FCA 186, rev'g 2011 FC 1486, var'd 2013 FCA 209. The Federal Court of Appeal overturned the Federal Court's decision invalidating the patent that claims clopidogrel bisulphate (sanofi-avent......
  • The Best of the Decade – Canadian Patent Law in the 2010s
    • Canada
    • JD Supra Canada
    • 14 Febrero 2020
    ...ingredient such as a salt, ester, enantiomer, solvate or polymorph. Sanofi-Aventis v Apotex Inc, 2013 FCA 186, rev’g 2011 FC 1486, var’d 2013 FCA 209. The Federal Court of Appeal overturned the Federal Court’s decision invalidating the patent that claims clopidogrel bisulphate (sanofi-avent......
  • Sound Prediction Applies To Mechanical Inventions (Intellectual Property Weekly Abstracts Bulletin - 9/30/2013)
    • Canada
    • Mondaq Canada
    • 7 Octubre 2013
    ...Thus the appeal and cross-appeal were both dismissed. PATENT ACTIONS Motion for reconsideration denied Sanofi-Aventis v. Apotex Inc., 2013 FCA 209 Drug: Sanofi-Aventis had previously been successful in its appeal of a patent infringement decision (decision here; our summary here). Sanofi-Av......
3 firm's commentaries
  • The Best Of The Decade – Canadian Patent Law In The 2010s
    • Canada
    • Mondaq Canada
    • 18 Febrero 2020
    ...ingredient such as a salt, ester, enantiomer, solvate or polymorph. Sanofi-Aventis v Apotex Inc, 2013 FCA 186, rev'g 2011 FC 1486, var'd 2013 FCA 209. The Federal Court of Appeal overturned the Federal Court's decision invalidating the patent that claims clopidogrel bisulphate (sanofi-avent......
  • The Best of the Decade – Canadian Patent Law in the 2010s
    • Canada
    • JD Supra Canada
    • 14 Febrero 2020
    ...ingredient such as a salt, ester, enantiomer, solvate or polymorph. Sanofi-Aventis v Apotex Inc, 2013 FCA 186, rev’g 2011 FC 1486, var’d 2013 FCA 209. The Federal Court of Appeal overturned the Federal Court’s decision invalidating the patent that claims clopidogrel bisulphate (sanofi-avent......
  • Sound Prediction Applies To Mechanical Inventions (Intellectual Property Weekly Abstracts Bulletin - 9/30/2013)
    • Canada
    • Mondaq Canada
    • 7 Octubre 2013
    ...Thus the appeal and cross-appeal were both dismissed. PATENT ACTIONS Motion for reconsideration denied Sanofi-Aventis v. Apotex Inc., 2013 FCA 209 Drug: Sanofi-Aventis had previously been successful in its appeal of a patent infringement decision (decision here; our summary here). Sanofi-Av......